CAS: 59160-29-1; Lidofenin

结构式图片

欧盟法规

ECHA物质C&L通报REACH预注册

上下游产品

2-chloro-N-(2,6-dimethylphenyl)acetamide 2,6-dimethylaniline

合成工艺路线路线简述

    📜2,6-二甲基苯胺 以 乙醇,水,丙酮 作为反应溶剂,化学反应 10.17H,反应生成 尼多非林
    参考文献:Mikiciuk-Olasik,Elzbieta; Wojewoda,Emilia; Bilichowski,Ireneusz,Acta Poloniae Pharmaceutica,2010,Vol. 67,# 2,P. 119-127
    标题:Mikiciuk-Olasik,Elzbieta; Wojewoda,Emilia; Bilichowski,Ireneusz,Acta Poloniae Pharmaceutica,2010,Vol. 67,# 2,P. 119-127

    海关参考信息

    专利信息


    专利号:US-2012177593-A1
    优先权日:2009-07-20
    标 题 :Synthesis of dendrimer conjugates
    发明人:BAKER JR JAMES R; ZHANG YUEHUA; THOMAS THOMMEY P; DESAI ANKUR MAHESH
    权利人:BAKER JR JAMES R; ZHANG YUEHUA; THOMAS THOMMEY P; DESAI ANKUR MAHESH; UNIV MICHIGAN
    摘要:The present invention relates to novel methods of synthesis of therapeutic and diagnostic dendrimers. In particular, the present invention is directed to novel dendrimer conjugates, novel methods of synthesizing the same, compositions comprising the conjugates, as well as systems and methods utilizing the conjugates (e.g., in diagnostic and/or therapeutic settings (e.g., for the delivery of therapeutics, imaging, and/or targeting agents (e.g., in disease (e.g., cancer, inflammatory disease) diagnosis and/or therapy, pain therapy, etc.)). Accordingly, dendrimer conjugates of the present invention may further comprise at least two different components for targeting, imaging, sensing, and/or providing a therapeutic or diagnostic material and/or monitoring response to therapy. Furthermore, the novel synthesis methods of certain embodiments of the present invention provide significant advantages with regard to total reaction time and simplicity.

    专利号:US-9220714-B2
    优先权日:2006-03-16
    标 题 :Nitrofuran compounds for the treatment of cancer and angiogenesis
    发明人:SAULNIER SHOLLER GISELLE L; SWAMY NARASIMHA; KALKUNTE STAYAN; SINGH RAKESH K; BRARD LAURENT; KIM KYU KWANG
    权利人:WOMEN AND INFANTS HOSPITAL OF RHODE ISLAND; UNIV BROWN; WOMEN AND INFANTS HOSPITAL RHODE ISLAND
    摘要:The invention is directed to the synthesis and use of nitrofuran compounds, especially Nifurtimox, as medicaments to treat cancer, especially neuroblastoma, and to inhibit angiogenesis. The invention also provides compositions, unit dosage forms, and kits comprising the compounds.

    专利号:US-2015352230-A1
    优先权日:2013-01-11
    标 题:Synthesis and isolation of dendrimer based imaging systems
    发明人:MULLEN DOUGLAS GURNETT; BAKER JR JAMES R; BANASZAK HOLL MARK M; HUANG BAOHUA; DOUGHERTY CASEY; BALL JACK
    权利人:UNIV MICHIGAN
    摘要:The present invention relates to novel methods of synthesis and isolation of antibodies conjugated with modular dendrimer nanoparticles. In particular, the present invention is directed to antibodies conjugated with novel modular dendrimer nanoparticles having precise numbers of imaging agents, methods of synthesizing the same, compositions comprising such antibodies conjugated with such modular dendrimer nanoparticles, as well as systems and methods utilizing the conjugates (e.g., in imaging settings) (e.g., in diagnostic and/or therapeutic settings) (e.g., for the delivery of therapeutics, imaging, and/or targeting agents).

    专利号:US-2012232225-A1
    优先权日:2009-08-26
    标 题:Synthesis and isolation of dendrimer systems
    发明人:BAKER JR JAMES R; BANASZAK HOLL MARK M; MULLEN DOUGLAS GURNETT; ORR BRADFORD G; DESAI ANKUR; SANDER LEONARD M; WADDELL JACK NEEL
    权利人:BAKER JR JAMES R; BANASZAK HOLL MARK M; MULLEN DOUGLAS GURNETT; ORR BRADFORD G; DESAI ANKUR; SANDER LEONARD M; WADDELL JACK NEEL; UNIV MICHIGAN
    摘要:The present invention relates to novel methods of synthesis and isolation of dendrimer systems. In particular, the present invention is directed to novel dendrimer conjugates with defined and limited numbers of ligand conjugates and high levels of structural uniformity, methods of synthesizing the same, compositions comprising the conjugates, as well systems and methods utilizing the conjugates (e.g., in diagnostic and/or therapeutic settings (e.g., for the delivery of therapeutics, imaging, and/or targeting agents (e.g., in disease (e.g., cancer) diagnosis and/or therapy, pain therapy, etc.)).

    专利号:US-9402911-B2
    优先权日:2011-12-08
    标题:Multifunctional small molecules
    发明人:BAKER JR JAMES R; HUANG BAOHUA M; THOMAS THOMMEY P
    权利人:UNIV MICHIGAN REGENTS
    摘要:The present invention relates to dendrimer synthesis. Specifically, the present invention relates to dendrimer compositions (e.g., scaffolds) capable of copper-free click conjugation for use in the synthesis of functionalized dendrimers, and methods of use of the same.

    专利号:US-8912323-B2
    优先权日:2009-10-30
    标题 :Multifunctional small molecules
    发明人:BAKER JR JAMES R; ZONG HONG; THOMAS THOMMEY P
    权利人:BAKER JR JAMES R; ZONG HONG; THOMAS THOMMEY P; UNIV MICHIGAN
    摘要:The present invention relates to dendrimer synthesis. Specifically, the present invention relates to triazine scaffolds capable of click chemistry for one-step synthesis of functionalized dendrimers, and methods of making and using the same.

    供应商参考报价(招募中)

    品牌试剂参考报价(招募中)

    📌 第三方产品分析报告

    ✅ COA系统入驻 | 共享模式

    主要参考文献


    1: Eckenrode AH, Ewing JA, Kotrady J, Hale AL, Smith DE. HIDA Scan with Ejection Fraction Is over Utilized in the Management of Biliary Dyskinesia. Am Surg. 2015 Jul;81(7):669-73. doi: 10.1016/j.ijsu.2016.09.084. Epub 2016 Sep 24. doi: 10.1053/j.gastro.2014.04.054. Epub 2014 Jul 23. doi: 10.1016/j.jss.2014.01.004. Epub 2014 Jan 9. doi: 10.1016/j.jaad.2012.09.044. doi: 10.1002/cmmi.1510. pii: bcr0620114379. doi: 10.1136/bcr.06.2011.4379.
    9: Brownie E, Cusick RA, Perry DA, Allbery S, Azarow KS. Pathologic changes in biliary dyskinesia. J Pediatr Surg. 2011 May;46(5):879-82. doi: 10.1016/j.jpedsurg.2011.02.021. doi: 10.1097/RLU.0b013e3181f49a7f. doi: 10.1007/s10620-010-1319-x. Epub 2010 Jul 15. doi: 10.1007/s00247-011-2202-4. Epub 2011 Jul 24. doi: 10.1097/01.NPR.0000403295.82092.20. doi: 10.1007/s11605-010-1342-4. Epub 2010 Sep 8. Epub 2007 Sep 17. doi: 10.1016/j.jpedsurg.2013.07.015.

    合成参考文献


    摘要:Journal of Nuclear Medicine., 18(997), 1977 []
    摘要:European Journal of Nuclear Medicine., 3(41), 1978 []
    参考文献:10.1136/gut.50.5.665
    摘要:Cicala M, Habib FI, Vavassori P, Pallotta N, Schillaci O, Costamagna G, Guarino MP, Scopinaro F, Fiocca F, Torsoli A, Corazziari E. Outcome of endoscopic sphincterotomy in post cholecystectomy patients with sphincter of Oddi dysfunction as predicted by manometry and quantitative choledochoscintigraphy. Gut. 2002 May;50(5):665–8.
    参考文献:10.1097/00003072-200205000-00005
    摘要:Zagar I, Anderson PJ, Gordon I. The value of radionuclide studies in children with autosomal recessive polycystic kidney disease. Clin Nucl Med. 2002 May;27(5):339–44. doi: 10.1097/00003072-200205000-00005.
    参考文献:10.1016/j.jpedsurg.2011.02.021
    摘要:Brownie E, Cusick RA, Perry DA, Allbery S, Azarow KS. Pathologic changes in biliary dyskinesia. J Pediatr Surg. 2011 May;46(5):879–82. doi: 10.1016/j.jpedsurg.2011.02.021.
    📝 需求与反馈
    尽可能描述清楚需求与问题信息
    ×

    通知